Celcuity

Develops targeted cancer therapies for patients with cancers involving the PAM pathway

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

About Celcuity

Celcuity is a biotechnology company developing targeted cancer therapies involving the PI3K/AKT/mTOR (PAM) pathway. Its first approved product, REVTORPYK (gedatolisib), is used to treat HR+/HER2-, PIK3CA wild-type advanced breast cancer in the United States.

The company is evaluating REVTORPYK in clinical trials for breast and prostate cancer, including global Phase 3 trials for first-line breast cancer treatment. Its open roles span clinical development, pharmaceutical development and operations, program management, and research and development.

Product: Develops and commercializes REVTORPYK (gedatolisib), a targeted cancer therapy, and evaluates it in clinical trials.

Jobs at Celcuity

No open positions in Europe right now.

Open roles at Celcuity in the Americas (1)

United States 1. From Celcuity's careers page or applicant tracking system; each role links to the employer.

More biotech & pharma companies

  • Celea Therapeutics

    Develops investigational therapies for serious respiratory diseases, including idiopathic pulmonary fibrosis
    United StatesBiotech & pharma
    New on Evolc
  • Cellanome

    Live-cell imaging and single-cell transcriptomics platform for biology research labs and biopharma companies
    United StatesBiotech & pharma
    New on Evolc
  • Cellarity

    AI and multi-omics drug discovery of oral medicines that correct dysfunctional cell states in complex diseases
    United StatesBiotech & pharma
    New on Evolc
  • Cellular Intelligence

    Develops AI and biology approaches to engineer cell fate for biomedical and drug-development applications
    United StatesBiotech & pharma
    New on Evolc
  • Centrillion Technologies

    High-density DNA chips and molecular measurement platforms for life science researchers and diagnostic partners
    Palo Alto, United StatesBiotech & pharma
    New on Evolc
  • Chai Discovery

    AI-based molecular design tools for pharmaceutical and life sciences companies developing medicines
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content delivery

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Google reCAPTCHAHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Gravity FormsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Privacy & consent

  • CookiebotHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.